A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma (vol 27, pg 2212, 2021)
Julie Westerlin Kjeldsen,Cathrine Lund Lorentzen,Evelina Martinenaite,Eva Ellebaek,Marco Donia,Rikke Boedker Holmstroem,Tobias Wirenfeldt Klausen, Cecilie Oelvang Madsen, Shamaila Munir Ahmed,Stine Emilie Weis-Banke,Morten Orebo Holmstrom,Helle Westergren Hendel,Eva Ehrnrooth,Mai-Britt Zocca,Ayako Wakatsuki Pedersen,Mads Hald Andersen,Inge Marie Svane NATURE MEDICINE（2022）
AI 理解论文
溯源树
样例
